Skip to main content
. 2018 Oct 31;9:2614. doi: 10.3389/fmicb.2018.02614

Table 4.

Effect of VCs produced by diverse F. oxysporum strains on the secretion of antifungal metabolites by four Trichoderma spp.

F. oxysporum strains Relative colony diameter (%)a
T. virens T. viride T. harzianum T. asperellum
NRRL26379 30.7 ± 2.6 (d) 55.8 ± 2.4 (b)
NRRL38499 56.9 ± 1.9 (a) 25.7 ± 3.1 (e)
NRRL54003 35.0 ± 2.2 (c) 24.8 ± 0.6 (e)
9605 15.2 ± 3.8 (g) no growth (g)
W61 19.6 ± 1.3 (f) no growth (g)
NRRL38272 24.1 ± 2.6 (e) no growth (g)
NRRL38487 no growth (h) 27.0 ± 1.7 (d) 59.6 ± 3.1 (a)
NRRL37611 25.0 ± 2.1 (e) no growth (g)
NRRL37616 no growth (h) 27.0 ± 2.1 (d) 61.4 ± 2.0 (a)
NRRL26029 no growth (h) 3.0 ± 1.8 (f) 59.9 ± 1.5 (a)
NRRL36118 17.9 ± 3.1 (g) no growth (g)
NRRL22518 34.0 ± 1.0 (c) 40.0 ± 2.5 (c)
NRRL22519 37.5 ± 2.1 (b) 68.0 ± 2.9 (a)
a

After exposure of individual Trichoderma strains to VCs from the listed F. oxysporum strains and Control (Trichoderma co-cultivated with un-inoculated PDA plate), F. oxysporum strain NRRL54003 was used to assess the degree of growth inhibition caused by secreted Trichoderma metabolites. Relative colony diameter (%) after each treatment was calculated using (Dtreatment/Dcontrol) × 100, where Dcontrol and Dtreatment indicated the colony diameters of F. oxysporum in control and VC treatments, respectively. Values shown correspond to the mean ± standard deviation (SD) of data from three replicates. Different letters indicate significant differences between treatments, according to Fisher's test at P = 0.05. – indicates no induction.